Evidence map›Paper›PMID 35933696›Full record

ArticleJournal of food biochemistry2022

Exploring the role of Xingren on COVID-19 based on network pharmacology and molecular docking.

Maoru Wang, Bin Yu, Jisheng Wang, Yu Wang, Libo Liang

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of food biochemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Maoru WangDrug Dispensing Department, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, China.
Bin YuDepartment of Pharmacy, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, China.ORCID 0000-0002-0397-6610
Jisheng WangDrug Dispensing Department, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, China.
Yu WangDepartment of Pharmacy, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, China.
Libo LiangDrug Dispensing Department, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, China.
Mianyang Third People's Hospital · CNUniversity of Electronic Science and Technology of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the outbreak of novel Coronavirus Pneumonia 2019 (COVID-19), the role of Almonds (Xingren) in the protection and treatment of COVID-19 is not clear. Network pharmacology and molecular docking were used to explore the potential mechanism and potential key targets of Xingren on COVID-19. A total of nine common targets between them were obtained, and these targets were involved in multiple related processes of GO and KEGG pathway enrichment analysis. Molecular docking showed that licochalcone B has the best binding energy (-9.33 kJ·mol

Indexed as

COVID-19 Drug TreatmentChalconesCyclooxygenase 2Drugs, Chinese HerbalHumansInterleukin-17Molecular Docking SimulationNetwork PharmacologyReactive Oxygen SpeciesChalconesCyclooxygenase 2Drugs, Chinese HerbalInterleukin-17licochalcone BReactive Oxygen SpeciesXingrenCOVID-19molecular dockingnetwork pharmacologyXingren

Identifiers

PMID35933696
PMCPMC9539046
OpenAlexW4290375592

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.